(Media-Newswire.com) - The new method is named the UCSF Cancer of the Prostate Risk Assessment ( CAPRA ). It is a risk stratification index that produces an easily-calculated score from 0 to 10 to predict the likelihood that men will experience a prostate-specific antigen ( PSA ) recurrence after surgery. Other existing risk-prediction tools, while offering comparable accuracy, have limitations, according to Matthew Cooperberg, MD, MPH, senior resident in urology at UCSF and lead author of the study.

Mayo Clinic researchers have found that a protein that initiates a "quality control check" during cell division also directs cell death for those cells damaged during duplication. This knowledge represents a potential "bulls eye" for targeting anti-tumor drugs. The findings appear in the current issue of Science.

By Renee Twombly
New clinical trial results linking a low-fat diet to a reduced risk of breast cancer are quite substantial and should be taken seriously by women wanting to help prevent the disease, according to the author of an editorial in the Journal of the American Medical Association.